Cargando…
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
Tubulointerstitial fibrosis is a common feature of kidney disease. Histone deacetylase (HDAC) inhibitors have been reported to attenuate renal fibrosis progression. Here, we investigated the effect of CG200745, a novel HDAC inhibitor, on renal fibrosis development in a mouse model of unilateral uret...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070546/ https://www.ncbi.nlm.nih.gov/pubmed/30068917 http://dx.doi.org/10.1038/s41598-018-30008-5 |
_version_ | 1783343687646838784 |
---|---|
author | Choi, Hong Sang Song, Ji Hong Kim, In Jin Joo, Soo Yeon Eom, Gwang Hyeon Kim, Inkyeom Cha, Hyunju Cho, Joong Myung Ma, Seong Kwon Kim, Soo Wan Bae, Eun Hui |
author_facet | Choi, Hong Sang Song, Ji Hong Kim, In Jin Joo, Soo Yeon Eom, Gwang Hyeon Kim, Inkyeom Cha, Hyunju Cho, Joong Myung Ma, Seong Kwon Kim, Soo Wan Bae, Eun Hui |
author_sort | Choi, Hong Sang |
collection | PubMed |
description | Tubulointerstitial fibrosis is a common feature of kidney disease. Histone deacetylase (HDAC) inhibitors have been reported to attenuate renal fibrosis progression. Here, we investigated the effect of CG200745, a novel HDAC inhibitor, on renal fibrosis development in a mouse model of unilateral ureteral obstruction (UUO). To examine the effects of CG200745 on renal fibrosis in UUO, C57BL/6 J male mice were divided into three groups: control, UUO, and CG200745 (30 mg/kg/day)-treated UUO groups. CG 200745 was administered through drinking water for 1 week. Human proximal tubular epithelial (HK-2) cells were also treated with CG200745 (10 µM) with or without TGF-β (2 ng/mL). Seven days after UUO, plasma creatinine did not differ among the groups. However, plasma neutrophil gelatinase-associated lipocalin (NGAL) levels were markedly increased in the UUO group, which were attenuated by CG200745 treatment. UUO kidneys developed marked fibrosis as indicated by collagen deposition and increased α-smooth muscle actin (SMA) and fibronectin expression. CG200745 treatment attenuated these fibrotic responses and suppressed UUO-induced production of transforming growth factor-beta1 (TGF-β) and phosphorylation of Smad-2/3. CG200745 treatment also attenuated UUO-induced inflammation as indicated by the expression of inflammatory markers. Furthermore, CG200745 attenuated phosphorylation of p38 mitogen-activated protein kinase in UUO kidneys. In HK-2 cells, TGF-β induced the expression of α-SMA and fibronectin, which were attenuated by CG200745 cotreatment. These results demonstrate that CG200745, a novel HDAC inhibitor, has a renoprotective effect by suppressing renal fibrosis and inflammation in a UUO mouse model. |
format | Online Article Text |
id | pubmed-6070546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60705462018-08-06 Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease Choi, Hong Sang Song, Ji Hong Kim, In Jin Joo, Soo Yeon Eom, Gwang Hyeon Kim, Inkyeom Cha, Hyunju Cho, Joong Myung Ma, Seong Kwon Kim, Soo Wan Bae, Eun Hui Sci Rep Article Tubulointerstitial fibrosis is a common feature of kidney disease. Histone deacetylase (HDAC) inhibitors have been reported to attenuate renal fibrosis progression. Here, we investigated the effect of CG200745, a novel HDAC inhibitor, on renal fibrosis development in a mouse model of unilateral ureteral obstruction (UUO). To examine the effects of CG200745 on renal fibrosis in UUO, C57BL/6 J male mice were divided into three groups: control, UUO, and CG200745 (30 mg/kg/day)-treated UUO groups. CG 200745 was administered through drinking water for 1 week. Human proximal tubular epithelial (HK-2) cells were also treated with CG200745 (10 µM) with or without TGF-β (2 ng/mL). Seven days after UUO, plasma creatinine did not differ among the groups. However, plasma neutrophil gelatinase-associated lipocalin (NGAL) levels were markedly increased in the UUO group, which were attenuated by CG200745 treatment. UUO kidneys developed marked fibrosis as indicated by collagen deposition and increased α-smooth muscle actin (SMA) and fibronectin expression. CG200745 treatment attenuated these fibrotic responses and suppressed UUO-induced production of transforming growth factor-beta1 (TGF-β) and phosphorylation of Smad-2/3. CG200745 treatment also attenuated UUO-induced inflammation as indicated by the expression of inflammatory markers. Furthermore, CG200745 attenuated phosphorylation of p38 mitogen-activated protein kinase in UUO kidneys. In HK-2 cells, TGF-β induced the expression of α-SMA and fibronectin, which were attenuated by CG200745 cotreatment. These results demonstrate that CG200745, a novel HDAC inhibitor, has a renoprotective effect by suppressing renal fibrosis and inflammation in a UUO mouse model. Nature Publishing Group UK 2018-08-01 /pmc/articles/PMC6070546/ /pubmed/30068917 http://dx.doi.org/10.1038/s41598-018-30008-5 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Choi, Hong Sang Song, Ji Hong Kim, In Jin Joo, Soo Yeon Eom, Gwang Hyeon Kim, Inkyeom Cha, Hyunju Cho, Joong Myung Ma, Seong Kwon Kim, Soo Wan Bae, Eun Hui Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease |
title | Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease |
title_full | Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease |
title_fullStr | Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease |
title_full_unstemmed | Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease |
title_short | Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease |
title_sort | histone deacetylase inhibitor, cg200745 attenuates renal fibrosis in obstructive kidney disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070546/ https://www.ncbi.nlm.nih.gov/pubmed/30068917 http://dx.doi.org/10.1038/s41598-018-30008-5 |
work_keys_str_mv | AT choihongsang histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT songjihong histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT kiminjin histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT joosooyeon histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT eomgwanghyeon histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT kiminkyeom histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT chahyunju histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT chojoongmyung histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT maseongkwon histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT kimsoowan histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease AT baeeunhui histonedeacetylaseinhibitorcg200745attenuatesrenalfibrosisinobstructivekidneydisease |